MLS® and COVID-19: a new success in treating interstitial pneumonia

02 October 2020 - Research -
Share

A new case confirms the effectiveness of MLS® as supporting therapy for treating pneumonia caused by COVID-19.

An obese patient with interstitial pneumonia who was treated for 4 days with MLS® Laser Therapy reported a concrete and progressive improvement in her critical parameters such as oxygen saturation, which increased to 97-99%, radiographic assessment of the pulmonary oedema (RALE) which went from 8 to 2, Brescia-COVID Respiratory Severity Scale (a score which assesses the gravity of the pneumonia and is used for patient progress management) which went from 4 to 0 and SMART-COP (a tool which monitors the seriousness of the pneumonia and predicts the need for intervening such as with a move to intensive care, etc.) which dropped from 5 to 1. Interleukin-6, ferritin and C-reactive protein also recorded a significant contraction.

The data were reported by the study “Adjunct low level laser therapy (LLLT) in a morbidly obese patient with severe COVID-19 pneumonia: A case report” whose conclusions indicate that use of MLS® Laser Therapy for the case in question recorded a significant improvement of the respiratory indexes, radiological results and inflammatory markers in just a few days.

A result which suggests that ASA’s therapy can safely be combined with conventional treatment for patients suffering from severe COVID-19 and morbid obesity.

Max 980px
Blog - obese patient with severe COVID-19 pneumonia assessment

You might also be interested in ...

See all articles

press - 01/09/2020
The NBC Boston News channel presents an important case report which demonstrates how MLS® Laser Therapy, applied to a patient affected by Covid-19 in order to treat pulmonary infection, markedly...
MLS Laser Therapy for the treatment of COVID19 pneumonia
blog - 24/08/2020
A very recent case report concerning the use of MLS® Laser Therapy supporting a patient suffering from severe pneumonia caused by Covid-19 reported a significant improvement in some basic parameters...
MLS Laser Therapy in a morbidly obese patient with severe COVID-19 pneumonia
Research
S.A. Sigman, S. Mokmeli, M.A. Vetrici Canadian Journal of Respiratory Therapy, 56:52–56, 2020
AAOS practice guideline knee osteoarthritis
Blog - 22/09/2021
This therapy can be concretely effective for treating both acute and chronic knee pain, as it reduces the inflammation and leads to faster healing, in addition to promoting tissue regrowth and to...
Press - 21/09/2021
Manuela, an osteochondritis sufferer, only needed one cycle of sessions with HIRO TT to continue training for the New York marathon.
Blog - 15/09/2021
The results of this study allow defining the neuroprotective mechanisms of the laser therapy carried out by MLS-MiS, to highlight its anti-inflammatory effect and to underline its potential benefit...